Aurora Cannabis Inc., a licensed medical cannabis supplier in Canada, has received conditional approval to graduate from the TSX Venture Exchange and list on the Toronto Stock Exchange. The advancement follows a series of recent development for the firm, including expansion into Germany, investments in Australia, and construction of their Aurora Sky cultivation facility – capable of producing more than 220,460 pounds of cannabis per year.
Aurora CEO Terry Booth said the “exciting milestone” reflects the company’s “remarkable pace of growth and expansion both across Canada and internationally.”
“Having uplisted from the [Canadian Securities Exchange] to the TSXV in October, 2016, we believe that now graduating to the TSX will enable us to address an even wider investor audience, both domestically and internationally,” he said in a press release. “We remain focused strongly on building shareholder value, and look forward to reporting on our progress as a member of Canada’s flagship stock exchange.”
Aurora will continue trading under the symbol “ACB” on the TSX and, in conjunction with the listing, the common shares will be voluntarily delisted from the TSXV prior to the commencement of trading on the flagship exchange.
As of June 29, Aurora surpassed 16,000 active registered patients – less than 18 months after its first product sale in January 2016.
Get daily cannabis business news updates. Subscribe